Old Web
English
Sign In
Acemap
>
authorDetail
>
Susumu Yamaguchi
Susumu Yamaguchi
Astellas Pharma
Medicine
Type 2 Diabetes Mellitus
Ipragliflozin
Diabetes mellitus
Internal medicine
5
Papers
51
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan
2021
International Journal of Clinical Oncology
Akira Yokomizo
Junji Yonese
Shin Egawa
Hiroshi Fukuhara
Hiroji Uemura
Kazuo Nishimura
Masayoshi Nagata
Atsushi Saito
Takumi Lee
Susumu Yamaguchi
Norio Nonomura
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study
2019
Diabetology international
Hisamitsu Ishihara
Susumu Yamaguchi
Ikko Nakao
Seitaro Asahina
Taishi Sakatani
Show All
Source
Cite
Save
Citations (5)
Open-Label Study to Assess the Efficacy of Ipragliflozin for Reducing Insulin Dose in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy
2019
Clinical Drug Investigation
Hisamitsu Ishihara
Susumu Yamaguchi
Toshifumi Sugitani
Yoshinori Kosakai
Show All
Source
Cite
Save
Citations (3)
Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study
2018
Diabetes Therapy
Hisamitsu Ishihara
Susumu Yamaguchi
Ikko Nakao
Taishi Sakatani
Show All
Source
Cite
Save
Citations (7)
Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a multi-centre, randomized, placebo-controlled, double-blind study
2016
Diabetes, Obesity and Metabolism
Hisamitsu Ishihara
Susumu Yamaguchi
Ikko Nakao
Akira Okitsu
Seitaro Asahina
Show All
Source
Cite
Save
Citations (36)
1